Skip to content
HowShorted

Omeros Corporation short interest in 2022

In 2022, Omeros Corporation's disclosed short interest ran from 17.51% of shares outstanding on 14 Jan 2022 to 13.94% on 30 Dec 2022, a change of -3.57 percentage points. The year's high was 21.19% on 15 Jun 2022 and its low 13.73% on 15 Dec 2022, averaging 17.16% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 33.26 days on 31 Oct 2022. Full history: Omeros Corporation.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Omeros Corporation in 2022

2022 in figures

Start of year
17.51% (14 Jan 2022)
End of year
13.94% (30 Dec 2022)
Change
-3.57 pp
High
21.19% (15 Jun 2022)
Low
13.73% (15 Dec 2022)
Average
17.16%
Highest days to cover
33.26 (31 Oct 2022)
SEC filings marked
8

Every report in 2022

Omeros Corporation short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202217.51%18.53
31 Jan 202218.11%13.36
15 Feb 202218.83%20.43
28 Feb 202218.21%26.37
15 Mar 202218.29%17.7310-K filed, results (8-K)
31 Mar 202217.85%25.02
14 Apr 202217.78%22.10
29 Apr 202217.97%16.08
13 May 202219.49%10.8310-Q filed, results (8-K)
31 May 202220.87%11.59
15 Jun 202221.19%11.31
30 Jun 202219.77%5.94
15 Jul 202219.34%4.02
29 Jul 202218.53%15.94
15 Aug 202216.51%13.7310-Q filed, results (8-K)
31 Aug 202215.87%15.42
15 Sep 202215.11%16.44
30 Sep 202215.02%19.33
14 Oct 202214.79%25.39
31 Oct 202214.38%33.26
15 Nov 202214.09%20.0210-Q filed, results (8-K)
30 Nov 202214.67%16.90
15 Dec 202213.73%17.61
30 Dec 202213.94%8.08

See also: Omeros Corporation's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.